Optimer Pharmaceuticals is quickly approaching its May 30th PDUFA as as heavy favourite to win a positive vote from the FDA to market its product, yet it seems that many investors are discounting the potential for a surprise negative outcome. The company is trying to obtain approval for its flagship product, fidaxomicin which could make [...]
The month of May has thus far been a very profitable one for investors in a number of small cap biotechs leading up to the June 2011 ASCO meeting, particularly ones that haven’t consequently fared too well once their respective binary events had met its endpoints. First up on the list is Oxigene, Inc. (NASDAQ:OXGN), [...]
With just a few weeks left on the calendar before the world’s largest oncology annual meeting, investors are already gearing up their portfolios for equities that could see exponential gains based on their potentially new research abstracts. The American Society of Clinical Oncology (ASCO) will begin on June 3rd and will feature everything from investigational [...]
Quick update to the trade. The bulls are firmly in control of Exelixis (NASDAQ:EXEL) with a cup being formed on the intraday chart and a possible handle formation next. A handle would give the ability to add more to this position, but I don’t anticipate resistance should be that strong. Unless volume is very low, [...]
With the market in correction mode, not much to update. Bounce opportunities are available, but you must have zero loyalty/emotional attachment to be successful at these. A bounce indicates the stock was recently falling. That implies a bounce will fall right back down, if not lower, than where it bounced from. If you buy thinking [...]
Following up on the previous post from the forums, here is an updated chart. Exelixis (NASDAQ:EXEL) has been resting near support lines at the bottom of the trading range that was established in early March. If after hours action Monday night is any indicator of the pre-market action Tuesday, we can expect EXEL to open [...]
Recent updates to the following trades. Join the discussion on the forums. Gran Tierra (GTE) Long Trade Magellan Petro (MPET) Long Trade Star Scientific (CIGX) Long Trade Apple (AAPL) Options Earnings Trade BGC Partners (BGCP) Long Trade Exelixis (EXEL) Long Trade Cheniere Energy (LNG) Long Trade Kodiak Oil (KOG) Long Trade
For those who follow me, this will be a shocker. I am running a trade in the financial sector. No, this doesn’t mean I’m bullish on the sector just yet. Diversification is our friend and being heavy leveraged towards energy and biotech, I saw an opportunity and jumped on it. BGC Partners (BGCP) is the [...]
Continuing with the overall energy theme today, Magellan Petro (NASDAQ:MPET) is a very speculative oil and natural gas play with a base forming to run up from. The current setup is near two support levels, with the key level being $2.35, so you know where to place your stop losses. Above that, we have significant [...]
Energy, specifically oil and natural gas, continues to be a favorite sector of many, including myself. In looking to capitalize on that strength, I have entered a trade in Gran Tierra Energy (AMEX:GTE). A successful trade in Exelixis (NASDAQ:EXEL) has been sold down significantly as the support was showing weakness. EXEL was profitable but not [...]
